$1.6M to Leidos
DRUG PRODUCT FORMULATION DEVELOPMENT, GMP MANUFACTURE, AND LONG-TERM STABILITY STUDIES OF BITOX FOR PHASE I CLINICAL TRIALS
- Company
- LDOSLeidos
- Recipient name in record
- LEIDOS BIOMEDICAL RESEARCH INC
- Awarded by
- Department of Health and Human Services · National Institutes of Health
- Value
- $1.6M
- Start date
- 15 Sep 2023
- End date
- 14 Sep 2026
- Award ID
- 75N91023F00021
- Source
- View official record on USAspending.gov ↗
The match between the recipient name and the listed company is made by StockRoz and can contain errors.